It was not a good Valentine’s Day for pharmaceutical giant Merck. On February 14, the company agreed to pay $688 million to settle two federal class-action lawsuits over the cholesterol drug Vytorin. This is but one example of why sometimes a separate products liability policy makes better sense than a more comprehensive Commercial General Liability policy.